| William S Mirando, M D | |
|
2885 N Ridge Rd E, Ashtabula, OH 44004-4134 | |
| (440) 998-3376 | |
| (440) 997-5751 |
| Full Name | William S Mirando |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 2885 N Ridge Rd E, Ashtabula, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386622942 | NPI | - | NPPES |
| 0892780 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35-06-0349M (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William S Mirando, M D 2885 N Ridge Rd E, Ashtabula, OH 44004-4134 Ph: (440) 998-3376 | William S Mirando, M D 2885 N Ridge Rd E, Ashtabula, OH 44004-4134 Ph: (440) 998-3376 |
News Archive
Fast growing transgenic fish can revolutionise commercial fish farming and relieve the pressure on overexploited fish stocks. But what happens in the natural environment if transgenic fish escape? Researchers at the University of Gothenburg have studied transgenic fish on behalf of the EU and are urging caution: Until further notice transgenic fish should be bred in closed systems on land, says Fredrik Sundström at the Department of Zoology, University of Gothenburg, Sweden.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has been awarded a cash grant under the Qualifying Therapeutic Discovery Project which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010.
Children exposed to family violence show the same pattern of activity in their brains as soldiers exposed to combat, new research has shown.
Researchers at the Cedars-Sinai and NeuroVision Imaging LLC have made it possible to identify the pathological markers of Alzheimer's using retinal scans. These scans are non- invasive and could be performed routinely in future to detect this dreaded form of degenerative brain disease. The paper was published online in the JCI Insight on 17th of August.
Dozens of suits against drug companies have been dismissed in federal and state courts because of a decision by the Supreme Court last year that makes it virtually impossible to sue generic manufacturers for failing to provide adequate warning of a prescription drug's dangers. This outrageous denial of a patient's right to recover fair damages makes it imperative that Congress or the Food and Drug Administration fashion a remedy.
› Verified 6 days ago
Bruce Philip Guido, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 420 W 24th St, Ashtabula, OH 44004 Phone: 440-992-5555 Fax: 440-992-3310 |